Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases

Microbiol Res. 2023 Mar:268:127291. doi: 10.1016/j.micres.2022.127291. Epub 2022 Dec 18.

Abstract

A new field of microbial research is the relationship between microorganisms and multicellular hosts. It is known that gut microbes can cause various endocrine system diseases, such as diabetes and thyroid disease. Changes in the composition or structure and the metabolites of gut microbes may cause gastrointestinal disorders, including ulcers or intestinal perforation and other inflammatory and autoimmune diseases. In recent years, reports on the interactions between intestinal microorganisms and endocrine system diseases have been increasingly documented. In the meantime, the treatment based on gut microbiome has also been paid much attention. For example, fecal microbiota transplantation is found to have a therapeutic effect on many diseases. As such, understanding the gut microbiota-endocrine system interactions is of great significance for the theranostic of endocrine system diseases. Herein, we summarize the relations of gut microbiome with endocrine system diseases, and discuss the potentials of regulating gut microbiome in treating those diseases. In addition, the concerns and possible solutions regarding the gut microbiome-based therapy are discussed.

Keywords: Fecal bacteria transplantation; Gut microbiome; Internal system diseases; Microbiology; Probiotic treatment.

Publication types

  • Review

MeSH terms

  • Endocrine System Diseases* / therapy
  • Gastrointestinal Diseases* / therapy
  • Gastrointestinal Microbiome*
  • Humans